94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1571555
This article is part of the Research Topic Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume III View all 3 articles
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
Provisionally accepted
Ivana Kutle 
Robert Polten 
Jan Lennart Stalp 
Jens Hachenberg Felix Todzey Ralph Hass 
Katharina Zimmermann Juliane von der Ohe 
Constantin Von Kaisenberg Lavinia Neubert 
Jan Christopher Kamp 
Dirk Schaudien Ann-Kathrin Seyda Peter Hillemanns 
Rüdiger Klapdor *
Michael Alexander Morgan *
Axel Schambach *- Hannover Medical School, Hanover, Germany
Corrigendum on: Kutle I, Polten R, Stalp JL, Hachenberg J, Todzey F, Hass R, Zimmermann K, von der Ohe J, von Kaisenberg C, Neubert L, Kamp JC, Schaudien D, Seyda AK, Hillemanns P, Klapdor R, Morgan MA, Schambach A. Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer. Front Immunol. 2024 Dec 16;15:1485461. doi: 10.3389/fimmu.2024.1485461. PMID: 39781381; PMCID: PMC11707549.In the published article, there was an error in Supplementary Figure 8. The graphical data shown in Supplementary Figure 8 was inadvertently duplicated, so that the same data is displayed twice in the figure. This error was present only in the submitted PDF version of the supplementary material, while the individually submitted figure files were correct. It appears that an intended edit was not properly incorporated into the final compiled PDF that was uploaded during submission, leading to this unintended duplication.
Keywords: cervical cancer, Immunotherapy, chimeric antigen receptor (CAR), CAR-NK cells, Mesothelin, chemotherapy, CAR-T cells
Received: 05 Feb 2025; Accepted: 06 Feb 2025.
Copyright: © 2025 Kutle, Polten, Stalp, Hachenberg, Todzey, Hass, Zimmermann, von der Ohe, Kaisenberg, Neubert, Kamp, Schaudien, Seyda, Hillemanns, Klapdor, Morgan and Schambach. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rüdiger Klapdor, Hannover Medical School, Hanover, Germany
Michael Alexander Morgan, Hannover Medical School, Hanover, Germany
Axel Schambach, Hannover Medical School, Hanover, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.